13F Filings History of TRV GP, LLC
- Form 13F summary
-
- TRV GP, LLC Form 13F history summarizes parsed U.S.-listed equity disclosures for this manager.
- Form 13F is generally due within 45 days after each calendar quarter ends.
- TRV GP, LLC reported 1 equity holding with a total reported market value of $18,903,000 for Q2 2021.
- Manager signature
- Kevin Gillis - Chief Operating Officer
- Manager location
- Boston, MA
13F snapshot
Latest parsed holdings, value, and filing-period context.
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow TRV GP, LLC with Pro and return when a new 13F portfolio filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
Holdings Value
Form 13F evidence
Quarterly portfolio filings
SEC-reported 13F quarters for this filer, ordered by the latest accepted filing.
Latest quarter
Q2 2021
Latest value
$18,903,000
Quarter delta
$0
Accepted
11 Aug 2021, 17:02
Rows shown
1-16 of 16
| Quarter | Holdings | SEC-reported value | Bought | Sold | Net | Top Holdings | Form Type | Accepted by SEC |
|---|---|---|---|---|---|---|---|---|
| Q3 2021 | 0 | $0 | $0 | -$18,903,000 | -$18,903,000 | 13F-HR | 05 Nov 2021, 16:47 | |
| Q2 2021 | 1 | $18,903,000 | $0 | $0 | $0 | SESN | 13F-HR | 11 Aug 2021, 17:02 |
| Q1 2021 | 1 | $10,638,000 | +$10,638,000 | -$6,536,000 | +$4,102,000 | SESN | 13F-HR | 12 May 2021, 16:46 |
| Q4 2020 | 1 | $6,536,000 | $0 | $0 | $0 | EBIO | 13F-HR | 16 Feb 2021, 06:45 |
| Q3 2020 | 1 | $6,778,000 | $0 | -$42,113,000 | -$42,113,000 | EBIO | 13F-HR | 06 Nov 2020, 16:26 |
| Q2 2020 | 2 | $45,599,000 | $0 | -$3,986,489 | -$3,986,489 | CNST, EBIO | 13F-HR | 07 Aug 2020, 19:02 |
| Q1 2020 | 2 | $50,932,000 | $0 | -$47,144,776 | -$47,144,776 | CNST, EBIO | 13F-HR | 11 May 2020, 16:17 |
| Q4 2019 | 2 | $147,971,000 | $0 | -$38,461,000 | -$38,461,000 | CNST, EBIO | 13F-HR | 05 Feb 2020, 16:51 |
| Q3 2019 | 3 | $63,726,000 | $0 | -$4,567,975 | -$4,567,975 | RYTM, CNST, EBIO | 13F-HR | 04 Nov 2019, 16:19 |
| Q2 2019 | 4 | $88,363,000 | $0 | $0 | $0 | RYTM, CNST, EBIO, ZFGN | 13F-HR | 06 Aug 2019, 16:25 |
| Q1 2019 | 4 | $100,986,000 | $0 | -$27,409,905 | -$27,409,905 | RYTM, CNST, EBIO, ZFGN | 13F-HR | 03 May 2019, 16:15 |
| Q4 2018 | 4 | $100,224,000 | $0 | $0 | $0 | RYTM, CNST, EBIO, ZFGN | 13F-HR | 28 Jan 2019, 16:05 |
| Q3 2018 | 4 | $120,256,000 | +$20,419,000 | -$51,885,162 | -$31,466,162 | RYTM, CNST, EBIO, ZFGN | 13F-HR | 29 Oct 2018, 16:04 |
| Q2 2018 | 4 | $158,768,000 | $0 | $0 | $0 | RYTM, KALA, EBIO, ZFGN | 13F-HR | 07 Aug 2018, 16:05 |
| Q1 2018 | 5 | $112,072 | $0 | $0 | $0 | RYTM, KALA, EBIO, ZFGN | 13F-HR | 19 Apr 2018, 17:11 |
| Q4 2017 | 5 | $221,278,000 | $0 | $0 | $0 | RYTM, CTMX, KALA, EBIO, ZFGN | 13F-HR | 13 Feb 2018, 13:19 |